<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02477423</url>
  </required_header>
  <id_info>
    <org_study_id>IRB15-0053</org_study_id>
    <nct_id>NCT02477423</nct_id>
  </id_info>
  <brief_title>Antibiotic Stewardship and Protection of the Developing Preterm Infant Microbiome</brief_title>
  <official_title>Antibiotic Stewardship and Protection of the Developing Preterm Infant Microbiome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Chicago</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether antibiotics given immediately after birth
      alter the development of the developing preterm infant's microbiome, which may further alter
      overall clinical outcomes.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">January 2018</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Development of the preterm infant microbiome</measure>
    <time_frame>18 months</time_frame>
    <description>The development of the preterm infant microbiome will be compared between groups through 16S ribosomal ribonucleic acid (rRNA) gene-based analysis of the infants stools.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical outcome - Chronic Lung Disease (CLD)</measure>
    <time_frame>4-12 weeks</time_frame>
    <description>Presence or absence of diagnosis at time of discharge from the hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical outcome - Retinopathy of Prematurity (ROP)</measure>
    <time_frame>4-12 weeks</time_frame>
    <description>Presence or absence of diagnosis at time of discharge from the hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical outcome - Intraventricular Hemorrhage (IVH)</measure>
    <time_frame>4-12 weeks</time_frame>
    <description>Presence or absence of diagnosis at time of discharge from the hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical outcome - Necrotizing enterocolitis</measure>
    <time_frame>4-12 weeks</time_frame>
    <description>Presence or absence of diagnosis at time of discharge from the hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical outcome - Death</measure>
    <time_frame>18 months</time_frame>
    <description>Survival from the neonatal intensive care unit, and survival beyond discharge will be determined via survey</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>Anticipated to be 4-12 weeks</time_frame>
    <description>Length of stay (in days) will be determined from the medical record</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days from birth to initiation of feeds will be determined from the medical record</measure>
    <time_frame>Varies based on gestational age - 0 to 2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Type of feeds (formula compared to breastmilk) during hospitalization.</measure>
    <time_frame>18 months</time_frame>
    <description>Post-discharge data will be collected via survey.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The number of times that feeds are held/discontinued due to feeding intolerance will be determined from the medical record.</measure>
    <time_frame>4-12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The total number of days the infant is on antibiotics will be determined from the medical record at the time of discharge.</measure>
    <time_frame>4-12 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Premature Birth of Newborn</condition>
  <condition>Enterocolitis, Necrotizing</condition>
  <arm_group>
    <arm_group_label>Randomized &amp; Blinded - Receiving Antibiotics</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The infants within this arm of the study meet the inclusion criteria as being low risk. They will be randomized to receive routine ampicillin and gentamicin for the initial 48 hours of their life as a routine rule-out sepsis. Stool samples will be collected throughout hospitalization and at 18 months of life.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Randomized &amp; Blinded - Receiving Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The infants within this arm of the study meet the inclusion criteria as being low risk. They will be randomized to receive placebo (saline) in place of ampicillin and gentamicin for the initial 48 hours of their life as a routine rule-out sepsis. Stool samples will be collected throughout hospitalization and at 18 months of life.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Routine, non-randomized care</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The infants within this arm of the study were consented, but did not meet the inclusion criteria as being low risk after the time of birth. They will receive all care per the primary medical team. Stool samples will be collected throughout hospitalization and at 18 months of life.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ampicillin</intervention_name>
    <description>Ampicillin will be given as routine antibiotic coverage for those in the active arm, as the standard initial antibiotic used within the neonatal unit. It may also be used for patients who are not eligible for randomization.</description>
    <arm_group_label>Randomized &amp; Blinded - Receiving Antibiotics</arm_group_label>
    <arm_group_label>Routine, non-randomized care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gentamicins</intervention_name>
    <description>Gentamicin will be given as routine antibiotic coverage for those in the active arm, as the standard initial antibiotic used within the neonatal unit. It may also be used for patients who are not eligible for randomization.</description>
    <arm_group_label>Randomized &amp; Blinded - Receiving Antibiotics</arm_group_label>
    <arm_group_label>Routine, non-randomized care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Normal saline will be given as placebo for those in the placebo comparator group.</description>
    <arm_group_label>Randomized &amp; Blinded - Receiving Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria for antibiotic randomization:

          1. Infant must be born between the gestational ages of 28 0/7 weeks and 34 6/7 weeks

             -AND-

          2. Infant must be born at investigator's home institution.

             -AND-

          3. Infant must be considered to have a low risk of infection by one of the following
             criteria:

               1. Delivered for maternal indications (Cesarean section or induction of labor for
                  maternal health, including pre-eclampsia, placental abruption, history of
                  intrauterine fetal demise (IUFD)/abruption, multiple gestation requiring preterm
                  delivery, etc) -OR-

               2. Delivered due to preterm labor to a mother without the diagnosis of
                  chorioamnionitis/maternal fever or prolonged rupture of membranes &gt;18 hours

        Exclusion Criteria for antibiotic randomization:

          1. Signs of clinical illness within the first 3 hours of life:

               1. 5-minute Apgar &lt;5

               2. Requiring vasoactive drugs

               3. Seizures

               4. Significant respiratory distress requiring supplemental oxygen &gt;40%

          2. Immature:Total (I:T) Ratio of &gt;0.2 on initial complete blood count (CBC)

          3. Congenital anomalies, including renal anomalies requiring serum antibiotic level
             monitoring

        ANY infant born between the gestational ages of 28 0/7 weeks and 34 6/7 weeks who do not
        meet inclusion criteria, with parental consent, can participate in the stool analysis only
        arm of the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>6 Hours</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nicole Grady, MD</last_name>
    <phone>773-702-6210</phone>
    <email>nicole.grady@uchospitals.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Erika Claud, MD</last_name>
    <phone>773-702-6210</phone>
    <email>eclaud@peds.bsd.uchicago.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Chicago Medical Center - Comer Children's Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 16, 2015</study_first_submitted>
  <study_first_submitted_qc>June 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 22, 2015</study_first_posted>
  <last_update_submitted>July 11, 2017</last_update_submitted>
  <last_update_submitted_qc>July 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Microbiome</keyword>
  <keyword>Antibiotics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Enterocolitis</mesh_term>
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Enterocolitis, Necrotizing</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Gentamicins</mesh_term>
    <mesh_term>Ampicillin</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

